Skip to main content

Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?

The Original Article was published on 01 December 2015

A recent meta-analysis published in Critical Care proposed presepsin as a novel valuable biomarker for discriminating systemic inflammation from true sepsis [1]. Unfortunately, this excellent paper did not provide information about the occurrence and eventual treatment of acute kidney injury (AKI) in the studied population. The kidney is one of the most frequently afflicted organs during sepsis and AKI may complicate up to half of the cases of blood culture-positive septic shock [2].

Little information is available on presepsin in patients with kidney dysfunction except that levels tend to increase with digressive glomerular filtration rate and are markedly high in patients with chronic renal failure or receiving hemodialysis [3]. More importantly, continuous renal replacement therapy (CRRT) is increasingly used to treat AKI in critically ill patients. C-reactive protein and procalcitonin, which are actually the most commonly used biomarkers to support diagnosis and to evaluate treatment in septic patients, are both significantly eliminated during CRRT [4].

Presepsin is fragmented from a larger glycoprotein and has a molecular weight of approximately 13 kDa. This is of particular concern because it theoretically exposes presepsin to significant convective elimination. Presepsin clearance may even be higher than expected because the molecule may “stick” to the highly adsorptive membranes incorporated in modern CRRT devices [5]. Thus, presepsin cannot be proposed as an accurate and clinically relevant sepsis biomarker until its behavior during CRRT is better specified.

Abbreviations

AKI:

Acute kidney injury

CRRT:

Continuous renal replacement therapy

References

  1. Zhang X, Liu D, Liu YN, Wang R, Xie LX. The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Crit Care. 2015;19:323.

    Article  Google Scholar 

  2. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the Systemic Inflammatory Response Syndrome (SIRS): a prospective study. JAMA. 1995;273:117–23.

    CAS  Article  Google Scholar 

  3. Nagata T, Yasuda Y, Ando M, Abe T, Katsuno T, Kato S, et al. Clinical impact of kidney function on presepsin levels. PLoS One. 2015;10, e0129159.

    Article  Google Scholar 

  4. Honore PM, Jacobs R, Hendrickx I, De Waele E, Van Gorp V, Spapen HD. ‘Biomarking’ infection during continuous renal replacement therapy: still relevant? Crit Care. 2015;19:232.

    Article  Google Scholar 

  5. Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, De Waele E, van Gorp V, et al. Newly designed CRRT membranes for sepsis and SIRS—a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J. 2013;59:99–106.

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick M. Honore.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

PMH and HDS designed the paper. PMH, RJ, IH, EDW, VVG and HDS participated in drafting the manuscript. All authors have read and approved the final version.

See related research by Zhang et al., http://www.ccforum.com/content/19/1/323

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Honore, P.M., Jacobs, R., Hendrickx, I. et al. Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?. Crit Care 19, 428 (2015). https://doi.org/10.1186/s13054-015-1146-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13054-015-1146-8

Keywords

  • Glomerular Filtration Rate
  • Septic Shock
  • Glomerular Filtration
  • Chronic Renal Failure
  • Systemic Inflammation